0 Bedömningar
ID

32973

Beskrivning

Study ID: 101877 Clinical Study ID: SAS101877 Study Title: A randomised, open label, 5-way crossover study to assess the systemic exposure of FP and salmeterol from SERETIDE/ADVAIR 250 without spacer, with Aerochamber -Plus and with -Max spacer, with VOLUMATIC spacer and SERETIDE/ADVAIR 500 DISKUS/ACCUHALER in adult subjects with mild or intermittent asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Advair DISKUS,Seretide Accuhaler; Viani,Seretide Diskus,Seretide Accuhaler,Seretide,Advair DISKUS Study Indication: Asthma The study consists of 5 treatment periods and a follow-up visit. The Screening includes Session 1 Treatment Period 1 includes Session 2 Treatment Period 2 includes Session 3 Treatment Period 3 includes Session 4 Treatment Period 4 includes Session 5 Treatment Period 5 includes Session 6 The Follow-up includes Session 7. This document contains the form for Compliance Restrictions/ Concomitant Medications and Adverse Event Enquiry. It has to be filled in for screening (only compliance restrictions), period 1-5 and for follow-up.

Nyckelord

Versioner (2)
  1. 22.11.18 22.11.18 -
  2. 23.11.18 23.11.18 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

22. November 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Systemic exposure of fluticasone propionate (FP) and salmeterol from different inhalation devices in adults with mild or intermittent asthma, (Study-)ID: 101877

    Engelsk

    Compliance Restrictions/ Concomitant Medications and Adverse Event Enquiry

    1 Formulär  
    Administrative data
    Beskrivning

    Administrative data

    Alias
    UMLS CUI-1
    C1320722
    Subject number
    Beskrivning

    Subject number

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2348585
    Screening, Treatment Period Number, Follow up
    Beskrivning

    Screening, Treatment Period Number, Follow up

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C0220908
    UMLS CUI [2,1]
    C0237753
    UMLS CUI [2,2]
    C1948053
    UMLS CUI [3]
    C1522577
    Compliance Restrictions
    Beskrivning

    Compliance Restrictions

    Alias
    UMLS CUI-1
    C1321605
    UMLS CUI-2
    C2065135
    Date of Assessment
    Beskrivning

    day month year

    Datatyp

    date

    Alias
    UMLS CUI [1]
    C2985720
    Did the subject comply with the Requirements and Restrictions as listed in the protocol as appropriate thus far?
    Beskrivning

    Requirements compliance

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0525058
    UMLS CUI [1,2]
    C2065135
    Is the subject aware of any forthcoming requirements?
    Beskrivning

    Aware of forthcoming requirements

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C1321605
    UMLS CUI [1,2]
    C0439801
    Comments to compliance
    Beskrivning

    Comments

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0947611
    UMLS CUI [1,2]
    C1321605
    Concomitant Medications and Adverse Event Enquiry
    Beskrivning

    Concomitant Medications and Adverse Event Enquiry

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C1519255
    Has the subject used any concomitant medications?
    Beskrivning

    If YES, record on CONCOMITANT MED/CATIONS page(s).

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2347852
    Has there been any change in the state of the subject's health?
    Beskrivning

    If YES record any adverse events as per protocol.

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0018759
    UMLS CUI [1,2]
    C0392747
    Tillbaka till toppen

    Similar models

    Compliance Restrictions/ Concomitant Medications and Adverse Event Enquiry

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Administrative data
    C1320722 (UMLS CUI-1)
    Subject number
    Item
    Subject number
    text
    C2348585 (UMLS CUI [1])
    Item
    Screening, Treatment Period Number, Follow up
    text
    C0220908 (UMLS CUI [1])
    C0237753 (UMLS CUI [2,1])
    C1948053 (UMLS CUI [2,2])
    C1522577 (UMLS CUI [3])
    Period Number
    Code List
    Screening, Treatment Period Number, Follow up
    CL Item
    Screening (1)
    CL Item
    Treatment Period 1 (2)
    CL Item
    Treatment Period 2 (3)
    CL Item
    Treatment Period 3 (4)
    CL Item
    Treatment Period 4 (5)
    CL Item
    Follow-up (FU)
    CL Item
    Treatment Period 5 (6)
    Item Group
    Compliance Restrictions
    C1321605 (UMLS CUI-1)
    C2065135 (UMLS CUI-2)
    Date of Assessment
    Item
    Date of Assessment
    date
    C2985720 (UMLS CUI [1])
    Item
    Did the subject comply with the Requirements and Restrictions as listed in the protocol as appropriate thus far?
    text
    C0525058 (UMLS CUI [1,1])
    C2065135 (UMLS CUI [1,2])
    Requirements compliance
    Code List
    Did the subject comply with the Requirements and Restrictions as listed in the protocol as appropriate thus far?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Is the subject aware of any forthcoming requirements?
    text
    C1321605 (UMLS CUI [1,1])
    C0439801 (UMLS CUI [1,2])
    Aware of forthcoming requirements
    Code List
    Is the subject aware of any forthcoming requirements?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Comments
    Item
    Comments to compliance
    text
    C0947611 (UMLS CUI [1,1])
    C1321605 (UMLS CUI [1,2])
    Item Group
    Concomitant Medications and Adverse Event Enquiry
    C2347852 (UMLS CUI-1)
    C1519255 (UMLS CUI-2)
    Item
    Has the subject used any concomitant medications?
    text
    C2347852 (UMLS CUI [1])
    Concomitant medications
    Code List
    Has the subject used any concomitant medications?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Has there been any change in the state of the subject's health?
    text
    C0018759 (UMLS CUI [1,1])
    C0392747 (UMLS CUI [1,2])
    Health state, change
    Code List
    Has there been any change in the state of the subject's health?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial